Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban

Rivaroxaban and apixaban are effective oral anticoagulants, but their usage has been associated with an increased risk of bleeding events. This study examined the bleeding and thromboembolic events of rivaroxaban and apixaban. Medical records from 114 patients (rivaroxaban n = 64, apixaban n = 80) t...

Descripción completa

Detalles Bibliográficos
Autores principales: ABDULLAH, Ahmad Salihin, TAN, Hwee Pheng, MOHD SAFFIAN, Shamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Penerbit Universiti Sains Malaysia 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036930/
https://www.ncbi.nlm.nih.gov/pubmed/35528821
http://dx.doi.org/10.21315/mjms2022.29.2.15

Ejemplares similares

Ejemplares similares